GTT Group’s Patent Equity Fund, Ideaship, Invests in Captis Biotechnology, Inc. to Develop Reliable and Inexpensive Diagnostic Platforms for Early Disease Detection
Captis Biotechnology, Inc. announced it has received an investment from Ideaship, a patent leveraged venture capital firm that provides patent development support for early stage startups. The investment will support Captis’ mission to develop diagnostic platforms to detect and treat illnesses such as ovarian cancer and precancerous pancreatic lesions with[…]
Read more